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Abstract:  
It is well known that bioactive glasses can cause a significant increase in pH due to 
the rapid release of calcium and/or sodium ions. Consequently, preconditioning of the 
glass is usually required prior to surgery to negate the effect of this sudden release of 
ions. However preconditioning for several days is far from ideal and also 
preconditioning is not practical for novel organic/inorganic sol-gel hybrids currently 
being developed since the organic phase will start to hydrolyze and dissolve. The 
present study describes a bioactive glass that dissolves without causing a significant 
change in pH from physiologically optimal values and requires no preconditioning 
prior to use. The bioactivity of the pH neutral glass, hydroxyapatite formation and 
cellular responses, are measured and compared directly with results from archetypal 
45S5 and S70C30 bioactive glasses. A hydroxyapatite layer was found to rapidly form 
(within one day) on the surface of the pH neutral glass upon reacting with simulated 
body fluid. In addition improved cell compatibility was observed compared with 45S5 
and S70C30 glasses. Therefore, this pH neutral glass has significant potential for bone 
repair applications. 
1. Introduction 
Since its discovery by Larry Hench et al. in 1969, melt-derived bioactive glass 45S5 
(45 wt%, SiO2, 24.5wt%, Na2O, 24.5wt% CaO, and 6wt% P2O5) has been widely used 
for repairing bone defects and in dental applications [1, 2]. When immersed in body 
fluid (or simulated body fluid, SBF), these glasses quickly form a layer of 
hydroxyapatite (HA) on their surfaces [3, 4]. Within the glass calcium and 
phosphorous aid bioactivity whist silicon acts as the host. Sodium oxide is present in 
the glass for two reasons; firstly it aids manufacturing, lowering the melt temperature, 
and secondly it disrupts the silicate network (i.e. cleaving the strong Si-O-Si bonds) 
increasing the dissolution of the active ions. Within these glasses sodium has no 
biological role other than the fact it is relatively inert and can easily be expelled from 
the body. In parallel to the melt quench derived bioactive glasses, sol-gel derived 
bioactive glasses have also been widely explored. Although sol-gel derived glasses 
with the a 45S5 composition have been successfully developed [5] as discussed above 
there is no biological advantage of incorporating sodium within these glasses. 
Furthermore, the hydroxyl groups incorporated into the glass during the synthesis 
essentially perform a similar role, disrupting the silicate network and aiding 
dissolution. Sol gel derived calcium phospho-silicates have therefore been widely 
explored e.g. 58S (58 wt% SiO2, 33wt% CaO and 9wt% P2O5), 77S (77wt% SiO2, 
14wt% CaO and 9wt% P2O5). However the phosphate content is not essential for 
bioactivity as phosphorous which is naturally present in the body combines with the 
released calcium to form apatite. Consequently most sol-gel bioactive glasses have 
focused on a simpler calcium silicate S70C30 (70mol% SiO2 and 30mol% CaO). All 
these glasses exhibit excellent bioactivity [6, 7] however they typically need 
preconditioning prior to use. 
It is generally accepted that the key step in bioactivity is the ion exchange 
between Ca and Na ions in the glasses and H3O+ protons in the media, however, this 
inevitably causes an increase in pH of surrounding media and thus causes cytotoxicity 
[8-11]. For this reason, preconditioning of bioactive glass samples is usually required 
before directly seeding cells on them, in order to reduce their cytotoxicity. For 
example, the S70C30 scaffolds need to be incubated for 3 days before cells were 
seeded [12]. An in vivo study by Swati and co-workers reported that 70S30C bioactive 
glass preconditioned for 3 days were very effective in regenerating a rat tibia defect, 
however, without this preconditioning the glasses showed no evidence of 
osseointegration [11]. 45S5 glass also needs to be preconditioned in physiological 
fluids for several days to improve their cellular adhesion and osteogenic activity [9]. 
In real surgeries, preconditioning is not always convenient. In this sense, a bioactive 
glass with neutral pH would be very beneficial. Furthermore, given that sol-gels have 
poor mechanical properties there is an increasing drive to develop organic / inorganic 
sol-gel hybrids [13-15]. It is not possible to pre-soak these hybrids to remove the 
alkaline ions from the sol-gel phase without beginning to hydrolyze and dissolve the 
organic components. It is therefore essential that pH neutral sol-gels are formulated.  
In principle, increasing the phosphorus content and/or lowering the sodium 
content should be reduce the pH increasing effect of a bioactive glass. However, in 
melt-quenching methods, lowering sodium content will increase the melting 
temperature and increasing phosphorus content can inhibit the glass forming ability. 
Furthermore any compositional changes will affect the network 
connectivity/dissolution and therefore the bioactivity. In conventional sol-gel methods 
the hydrolysis of alkyl phosphates is very slow and phosphates tend to precipitate 
instead of gelation[16]. In a previous study, we found that when phytic acid was 
employed as the phosphorus precursor, much higher phosphorus concentrations could 
be used in the sol-gel process [17-20], and a much wider range of bioactive 
compositions could be achieved in the CaO-P2O5-SiO2 ternary glass.  
Several studies have reported how the gelling process can be controlled by 
altering the pH through the addition of acids and bases, also several studies have 
looked at the effect pH of the media has on the dissolution of the glass within the 
given media. However there has been very little reported on tailoring the glass to 
dissolve in a pH neutral manner. In theory it should be possible to control the pH by 
adjusting the sodium, calcium and phosphorus content. However in reality it is 
challenging to predict the composition required to develop a pH neutral glass due to 
unknown variables in compositional / structural effects on dissolution rates and 
precipitation rates. For example the environment of phosphorous (Qn) will determine 
it solubility, whilst sodium ions are much smaller and more mobile that calcium ions 
and leach much more rapidly causing a rapid rise in pH. Calcium and phosphorous 
will precipitate thereby removing these ions from the solution. 
For the present study a sodium free ternary CaO-P2O5-SiO2 glass was selected. It 
was assumed that phosphorous would adopt an orthophosphate environment as widely 
reported for these types of bioactive glasses. It was also assumed that calcium would 
leach relatively easily from the glass structure. Since precipitation of amorphous 
calcium phosphate, a likely precursor for the formation of bone mineral, occurs 
around neutral pH we tailored the glass composition to closely mimic the required 
Ca/P ratio. Sintered hydroxyapatite, Ca10(PO4)6(OH)2, has a calcium to phosphorous 
ratio of 1.67 whilst precipitated hydroxyapatite has a less defined composition, 
Ca10−x(HPO4)x(PO4)6−x(OH)2−x and a calcium to phosphorous ratio of between 
1.33–1.67. For the present study we adopted a (CaO)0.35(P2O5)0.108(SiO2)0.542 
composition with a calcium to phosphorous ratio of 1.62 which is close to the ideal 
composition for sintered HA and lies within the optimal range for precipitate 
hydroxyapatite. 
 In the current work we explore if a pH neutral bioactive glass could be achieved 
by increasing the phosphorus content without reducing the bioactivity. We therefore 
investigated the in vitro performance on a novel pH neutral bioactive glass in the 
context of bone repair. 
 
2. Materials and Methods 
Materials and preparation 
The following precursors were used without further purification in the sol-gel 
preparation. Tetraethyl orthosilicate (TEOS, ≥99.0%) and Ca(NO3)2·4H2O were 
purchased from Sinopharm Chemical Reagent Co., Ltd. Phytic acid (50 wt% aqueous 
solution) was purchased from Sigma Aldrich. Bioactive glass (45S5) was purchased 
from Schott in Germany and used as a control glass. 
Bioactive glass S70C30 was prepared as previously reported [21]. TEOS (10mL) 
was hydrolyzed for 30 min in a mixture of ethanol and water at room temperature 
with 2N HNO3 as a catalyst. Ca(NO3)2·4H2O (4.53g) was added gradually whilst 
continuous stirring. The molar ratio of water to TEOS was 12:1. The obtained clear 
sol solution was sealed in a polypropylene container and left to gel. The gel was then 
aged at 60°C for a week, followed by drying at 120°C for a further week and then 
stabilized at 600°C for 1h to obtain the S70C30 glasses which were ground into fine 
powders (<38 μm). 
Bioactive glass (P2O5)0.108(SiO2)0.542(CaO)0.35 (named as PSC_pH here) was 
prepared as reported by Li et al. [19]. In brief, phytic acid (0.8mL) was firstly mixed 
with ethanol and water at ambient temperature, then TEOS (2.91mL) was added 
through a syringe during stirring. After 1 h, Ca(NO3)2·4H2O powder (1.99g) was 
added until a transparent solution formed (the sol), which was sealed in polypropylene 
containers and left to gel. The resultant gel was aged at 60°C for one week and then at 
120°C for another two weeks, and then stabilized at 600°C for 1 h to obtain PSC-pH 
glasses which were also ground into fine powders. The compositions of 45S5, 
S70C30 and PSC-pH bioactive glasses are summarized in Table 1. 
X-ray diffraction (XRD) spectra were collected using a Rigaku (D/MAX 2500) 
instrument with Cu Kα radiation (λ=1.54Å), operated at 40 kV and 200 mA. Data was 
collected from the surface of pellets with 2θ values between 10° to 60° and a step size 
of 0.02°. 
Solid state 31P NMR spectroscopy was measured using a Bruker Avance III 400 MHz 
instrument at a Larmor frequencies of 161.58 MHz. The experiments were conducted 
at a spinning speed of 12 kHz and referenced using ammonium dihydrogen phosphate 
(NH4H2PO4). 
Table 1. Composition of 45S5, S70C30 and PSC-pH bioactive glasses in molar %. 
Component 45S5 (mol%) S70C30 (mol%) PSC-pH (mol%) 
SiO2 46.1 70 54.2 
CaO 26.9 30 35 
P2O5 2.6 ― 10.8 
Na2O 24.4 ― ― 
 
Bioactivity testing and dissolution measurements 
150 mg of each glass powder (45S5, S70C30 and PSC-pH) was pressed into 
pellets and immersed in 100 mL of SBF at 36.5±0.5°C [4, 15, 22, 23]; each sample 
was measured in triplicate. After immersing in SBF for different intervals the pellets 
were washed gently with pure water and left to dry in a desiccator without heating. 
During the course of immersion, ion concentration and media pH were monitored 
regularly by ICP-MS (Agilent 7900) and a pH meter (PB-10, Sartorius). Apatite 
formation was evaluated using FTIR, scanning electron microscopy (SEM) and XRD 
as described above.  
FTIR: Fourier transform infrared spectra were collected in the range 4000-400cm-1 on 
a Bruker Equinox 55 instrument. All samples were diluted with dry KBr, ground into 
fine powders and pressed into pellets. 
SEM: The samples were coated with a thin layer of gold (Au) by sputtering (SCD 
500). The surface development was observed using a Hitachi (4800) instrument 
operating at a voltage of 15 kV. 
Textural Characterization 
Pore texture of the PSC-pH, 45S5 and S70C30 glasses were analyzed using 
ASAP 2020 apparatus. Glasses were first degassed in vacuum oven at 200°C for 10 h 
to remove moisture from the pores and then analyzed with nitrogen adsorption to 
determine the specific surface area. 
Degradation studies 
PSC-pH (150mg) pellets, in triplicates, were immersed in 100 ml of SBF at 
36.5±0.5°C and magnetically stirred at 120 rpm. At different time points (1, 3, 5, 7, 14 
and 28d), the glass pellets were removed from their containers and dried under 
vacuum prior to weighing. To obtain the rate of weight loss, the initial weight (M0) of 
each sample was measured as well as the weight at time t (Mt) to give a weight loss %: 
weight loss%=(M0-Mt)/M0×100%. 
Cell evaluation 
Cell culture. A preosteoblast cell line (MC3T3-E1; ATCC, CRL-2593, Rockville, 
MD, USA) was used to investigate the cell compatibility in vitro. The MC3T3-E1 
cells were cultured in a humidified incubator under an atmosphere containing 5% CO2 
at 37°C. Dulbecco’s Modified Eagle Medium (α-MEM) supplemented with fetal 
bovine serum (FBS, 10%), penicillin (100μg/mL) and streptomycin (100μg/mL) was 
used as the culture medium. Cells were sub-cultured every 5 days and maintained at 
37°C in a humidified incubator with 5% CO2. 
Cell Cytotoxicity and Proliferation. The glass extracts were prepared as previously 
shown [24]. 100mg of PSC-pH (or S70C30 / 45S5) bioactive glass, which had been 
previously sterilized under UV light for 12 h, were soaked in 20mL of α-MEM 
preheated to 37 °C. After 24 h at 37°C under sterile conditions, α-MEM was filtered 
to obtain glass extracts, which were used as culture medium with 10% fetal bovine 
serum (FBS). 
A Cell Count Kit-8 (CCK-8, Beyotime, Jiangsu, China) was employed to 
quantitatively evaluate cell viability. Two experimental procedures were carried out to 
evaluate the cell cytotoxicity and proliferation: (1) MC3T3-E1 was seeded on 96-well 
culture plates at a density of 1.7×104 cells/mL, after cell adhesion was verified, the 
culture medium was replaced by different extracts of glasses (45S5, S70C30 and 
PSC-pH). Cells incubated in α-MEM without glass extracts were used as the control. 
The cells were incubated in the culture plates for 48 h; (2) MC3T3-E1 was seeded on 
96-well culture plates at a density of 1.7×104 cells/mL, after cell adhesion was 
verified, then 5% of the different glass pellets previously sterilized under UV light for 
12 h was added to the culture medium for 2, 4 and 7 d. Then, the CCK-8 solution (20 
μL per well) was added and incubated for 4 h at 5% CO2 and 37°C. 100 μL of the 
reacted reagent from each well was transferred to 96-well plates, and the absorbance 
at 450 nm was determined using a microplate spectrophotometer (MD, SpectraMax 
M2, USA). Six parallel replicates of each sample at each time point were measured so 
that statistical analysis could be performed. 
Cell Morphology. The glass powders were pressed into discs (~100mg, 13mm in 
diameter and 0.7mm in thickness). First, the discs were disinfected in 70% ethyl 
alcohol solution for 2 h, washed twice in sterile phosphate buffer solution (PBS) for 
30 min, and then sterilized under high-intensity UV radiation for 4 h. Afterwards, the 
discs were placed in a 24-well culture plate. MC3T3-E1 cell suspensions (10000 cells 
per well) were cultured in discs for 1 d. Then, the cell-discs were washed with PBS, 
and fixed with 2.5% glutaraldehyde at 4°C for 24 h. The cell-discs were dehydrated 
using ethanol solutions (50, 75 and 95 wt%) and observed by SEM. 
Statistical analysis 
The one-way analysis of variance (ANOVA) was used to evaluate significant 
differences between means in the measured data. Each experiment was repeated at 
least three times. All quantitative data is presented as mean ± standard deviation. 
 
Results and discussion 
XRD spectra 
Figure 1 shows the XRD spectra of PSC-pH, 45S5 and S70C30 glasses. As 
shown by the absence of Bragg peaks all the materials are amorphous. PSC-pH 
glasses were tested in comparison to 45S5 and S70C30 glasses because these two 
glasses have been extensively studied both in vitro and in vivo [25]. 
31P NMR. As shown in Figure 2 the 31P NMR spectra is dominated by a single 
peak ~ -2ppm which is assigned to orthophosphate, Q0, species. A second feature ~ 
-8ppm is assigned to Q1 moieties. Q0 species account for 90% of the phosphorous 
environment with the remaining 10% accounted by Q1 species. This justifies the 
earlier assumption that phosphorous is loosely incorporated into the structural 
network and will be readily leached and prevents the pH release caused by the of 
calcium ions.  
Dissolution profiles 
The concentration of ions in the solutions surrounding the glasses 45S5, S70C30 
and PSC-pH are presented in Figure 3. Figures 3 a, b and c show the concentrations of 
silicon, calcium, and phosphorous species which are a summation of the ions released 
from glasses and the initial concentration of ions present in SBF. The concentration of 
silicon monotonically increased as a function of time. Si leaches rapid from S70C30 
in the first hour, with 45S5 and PSC-pH showing significantly lower concentration of 
Si. This trend is maintained and silicon concentrations for S70C30, 45S5 and PSC-pH 
increase from 2.9ppm to approximately 380ppm, 306ppm and 261ppm, respectively 
in 24 h. Silicon release is a result of the glass dissolution caused by the breaking up of 
the outer silica network, and has previously been reported to be in the form of 
monosilicic acid Si(OH)4 [26]. After the initial rapid release of Si ions from 70S30C 
and 45S5 during the first hour the gradients become relatively similar for all the 
glasses studied.  
The calcium concentration increases rapidly during the first few hours (1-3 h) for 
the 45S5 and 70S30C as ions are released from the glasses, only a very small increase 
in Ca concentration is observed for the PSC-pH sample in the first few hours. The Ca 
concentration then gradually decreases as it combined with P and precipitates. The 
PSC-pH sample has a relatively flat calcium concentration as a function of time 
implying that either Ca is released relatively slowly from this glass composition or 
that the high P content binds with the Ca and precipitates as Ca-phosphate.  
For 45S5 and S70C30 samples, the concentration of phosphorous decreases sharply 
with time, and a depletion of calcium ions is also observed between 3-12 h. This is 
attributed to the precipitation of calcium ions by phosphorous ions from the 
dissolution media, forming the Ca-P rich layer on the sample surface when the 
solution is oversaturated. However, for PSC-pH sample, the concentration of 
phosphorous only decreases in the first 1 h, after which it stays approximately 
invariable. This is attributed to the constant release of P ions from the PSC-pH glass 
which contains a high phosphate content. 
pH values are shown in Figure 4 for each of the samples. It can be seen that the 
pH of 45S5 and S70C30 increased as a function of time, whereas the pH of PSC-pH 
was virtually stable. The abrupt increase in calcium concentration in the first few 
hours (Figure 3c) is similar to the pH increases (Figure 4), supporting the argument 
that the ion exchange between Ca2+ ions in the glasses and H3O+ protons in the SBF 
media is one of the major reasons for pH increase. The PSC-pH has a higher and 
constant phosphorus concentration and helps stabilize the pH, whereas, insufficient 
phosphorus ions of 45S5 and S70C30 samples cannot precipitate released calcium 
ions in time, which leads to the increase in pH value. The relatively stable pH is one 
of the benefits of having a high phosphorus content in the bioactive glass as discussed 
earlier. 
 
Degradation studies 
It has been reported that higher phosphate contents in glasses increases degradation 
[16]. However, as shown in the above dissolution profiles (Figure 3), PSC-pH glasses 
with higher phosphate content have lower ion release concentration than other two 
glasses (45S5 and S70C30). Thus a preliminary evaluation of the PSC-pH glass 
degradation was conducted by mass loss upon immersion in SBF, as shown in Figure 
5. Mass loss of PSC-pH increases in an approximately linearly with the time (as a 
function: y=0.785x), which matches the bone repair process very well. On the 
contrary, 45S5 glasses have been reported to degrade slowly, taking 1 to 2 years to 
disappear from the body [27, 28]. The dissolution results further indicate that the 
lower released ion concentrations in PSC-pH sample is a result of precipitation of 
calcium ions by phosphate ions rather than lower glass degradation. 
Morphology of bioactive glass particles 
As shown in Table 2, PSC-pH glass samples have higher BET surface area than 
other two composition (45S5 and S70C30). Whilst it is known that samples with 
higher specific surface areas are generally more reactive upon contacting SBF they 
also tend to be much more soluble. However in the present study the PSC-pH glass 
with high phosphate content is found to degrades at a rate suitable for bone repair and 
regeneration applications, whilst the pH value and released ion concentration increase 
slowly as a function of time. This means that differences in the ion release rates are 
not dominated by the specific surface area, otherwise, PSC-pH should have the 
highest released ion concentrations as well as pH. Again, it suggests that the 
dominating factor governing the dissolution behaviors of these glass samples is their 
chemical compositions. 
Table 2 BET surface area of 45S5, S70C30 and PSC-pH glass pellets. 
sample 45S5 S70C30 PSC-pH 
BET surface area (m2/g) 0.19* 31.38 118.91 
*the value was evaluated from average particle size and density because it is too 
small to be measured by BET apparatus. 
Hydroxyapatite formation  
It has been reported that hydroxyapatite forms on the surface of 45S5 and S70C30 
within 1d immersion in SBF [7, 9]. As discussed previously we have found that 
PSC-pH was superior to both 45S5 and 70S30 in terms of the combined release rate 
of Ca and P which prevents a large shift in pH evolution of surrounding media, 
furthermore PSC-pH has a larger surface area. Nevertheless, as mentioned earlier, this 
should not at the expense of reduced hydroxyapatite formation ability (i.e. in vitro 
bioactivity). Figure 6 shows the XRD and FTIR spectra of the PSC-pH glasses after 
immersed in SBF for different times. As shown in Figure 6a, the sample before SBF 
immersion is totally amorphous. Hydroxyapatite (HA) diffraction peaks appear after 
only 1 d immersion and then increase in magnitude with immersion time, confirming 
hydroxyapatite formation on the surface of these materials. Monoclinic HA is shown 
as the reference standard. In the FTIR spectra, the double peaks at 603 and 567cm-1 
are assigned to crystalline phosphate. The FTIR spectra (Figure 6b) shows that before 
immersion, no phosphate appears for PSC-pH glass, whereas, phosphate signals are 
detected after only 1 d immersion, which becomes more evident with time, again 
confirming the formation of apatite. 
SEM results also confirm the formation of HA on the surface of the PSC-pH glass 
after immersion in SBF (Figure 7). It can be seen that both hemispherical and needle 
like apatite are formed after only 1 d immersion, and the apatite HA layer becomes 
denser with time. These results are consistent with the XRD and FTIR results, 
demonstrating the good bioactivity of PSC-pH. The HA formation behavior of 
PSC-pH is equivalent if not slightly better previously reported 45S5 and S70C30 
glasses [7, 9] [29]. 
Cell viability and morphology 
It is known that cells are sensitive to pH changes and are generally cultured in 
media with the pH value of 7.2 - 7.4 [8]. Apoptosis or necrosis is likely to be caused 
by the changes in extracellular pH as the potential across the cell membrane may be 
altered and ion exchange systems may be inhibited such as Na+/H+ and Ca2+, which 
may result in a build-up of intracellular H+ and denature the proteins. The reported 
glasses, such as 45S5 and S70C30, drive higher pH alterations because of the release 
of alkali elements into the tissue culture media[11, 26]. Therefore，significant effort 
has been devoted to evaluating the effect of preconditioning bioactive glasses on cell 
response. Preconditioning has been shown to minimize pH change and reduce cell 
apoptosis, and also to improve cellular adhesion and osteogenic activity [8, 9, 11]. In 
this work, all the glasses (PSC-pH, 45S5 and S70C30) were used for cell culture 
without preconditioning. As shown in Figure 8a, at the extracts concentration of 5 
mg/mL, 45S5 and S70C30 have significant cytotoxicity, whereas, there is no 
significant cytotoxicity for the PSC-pH samples. PSC-pH samples also have better 
cell proliferation comparing to 45S5 and S70C30 samples (Figure 8b), especially at 
7d. 
 Figure 9 shows the morphology of cells adhered on PSC-PH discs. It is found that 
MC 3T3-E1 cells adhered well on the surface of PSC-pH samples after culturing for 1 
d. After culturing for 3 d, MC 3T3-E1 cells show filopodium morphology and spread 
well on the discs, suggesting that the cells were able to grow and proliferate on the 
PSC-pH samples without pretreatment. However, there is no cell adhesion found for 
45S5 and S70C30 discs (not shown here), in agreement with previous studies. This 
means that PSC-pH samples have better cell compatibility than the other two typical 
bioactive glass samples when directly seeded with MC 3T3-E1 cells. Therefore, this 
new bioactive glass (PSC-pH) has the potential to be used in bone repairing. Further 
in vivo studies are currently being undertaken. 
Conclusion 
The in vitro bioactivity of a new bioactive glass (PSC-pH) with high phosphorus 
content was explored in this study. It was found upon when PSC-pH glasses were 
immersed in SBF the pH values of the media were stable and maintained at near the 
physiological optimal. 45S5 and S70C30 glasses exhibited a significant pH increase 
as previously reported. The higher phosphorus content in the PSC-pH glass ensured 
that phosphorous degraded at an appropriate rate such that it could combine with the 
dissolving calcium allowing them to precipitate into an amorphous calcium phosphate. 
The PSC-pH glass does not remove the phosphorous ions from the media as quickly 
and a higher phosphorus ion concentration remains. Consequently the concentration 
of calcium ions that remained in the media were significantly lower for the PSC-pH 
glass compared to 45S5 and S70C30. This is because of the rapid formation of HA of 
PSC-pH (high bioactivity). PSC-pH also had better cell compatibility when directly 
seeded with cells, where good cell adhesion was observed. On the contrary, no cell 
adhesion was found for 45S5 and S70C30 under the same cell culture conditions. 
Therefore, PSC-pH glass is a promising new bone repairing material in terms of 
biodegradation and biocompatibility. The PSC-pH glass has significant potential as a 
bioactive glass that does not require preconditioning prior to use and for use in novel 
organic/inorganic hybrids where it is not possible to precondition the sol-gel phase 
without disrupting the organic phase. 
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 Figure 1. XRD spectra of PSC-pH, 45S5 and S70C30 glasses. The datasets are offset 
for clarity. 
 
 
Figure 2. 31P NMR. The experimental data is given by the crosses, Gaussian fits are 
given by the broken curves and the solid curve is the total fit. 
 
 
 
Figure 3. Concentration of Si, Ca and P ions in the surrounding media as determined 
by ICP are given in Figures 3(a), (b) and (c) respectively for 45S5, S70C30 and 
PSC-pH in SBF. 
 
Figure 4. pH values of PSC-pH, 45S5 and S70C30 glasses as a function of time.   
 
 
Figure 5. Weight loss in SBF solution as a function of soaking time for PSC-pH glass. 
 
 
Figure 6. XRD (a) and FTIR (b) spectra of PSC-pH glasses after immersing in SBF 
for different times (0, 1, 3 and 7 d).   
 Figure 7. SEM images of PSC-pH glass after immersion in SBF for different time 
periods (0, 1, 3, 7 d). 
 
 
Figure 8. CCK-8 assay for MC 3T3-E1 cells cultured (a) in the absence (control) or in 
the presence of different glass (45S5, S70C30 and PSC-pH) extracts (5mg/mL) for 48 
h (b) with 5% of 45S5, S70C30 and PSC-pH glass pellets for different times (2, 4 and 
7d) (statistical significance: ***p < 0.005,**p < 0.01). 
 
Figure 9. SEM images of preosteoblast MC 3T3-E1 cells cultured on PSC-pH discs 
for 1d and 3d. 
 
 
 
 
 
 
 
